These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20685676)

  • 21. Safety and effectiveness of antithrombotic strategies in older adult patients with atrial fibrillation and non-ST elevation myocardial infarction.
    Fosbol EL; Wang TY; Li S; Piccini JP; Lopes RD; Shah B; Mills RM; Klaskala W; Alexander KP; Thomas L; Roe MT; Peterson ED
    Am Heart J; 2012 Apr; 163(4):720-8. PubMed ID: 22520540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antithrombotic therapy in elderly patients with atrial fibrillation: effects and bleeding complications: a stratified analysis of the NASPEAF randomized trial.
    Pérez-Gómez F; Iriarte JA; Zumalde J; Berjón J; Salvador A; Alegría E; Maluenda MP; Asenjo S; Perez-Saldaña R; de la Torre RG; Bover R; Fernández C
    Eur Heart J; 2007 Apr; 28(8):996-1003. PubMed ID: 17158523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1.
    Lee BH; Park JS; Park JH; Park JS; Kwak JJ; Hwang ES; Kim SK; Choi DH; Kim YH; Pak HN
    J Cardiovasc Electrophysiol; 2010 May; 21(5):501-7. PubMed ID: 20021521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The unmet need of patients with atrial fibrillation: AVERROES and the novel oral anticoagulants.
    Hart RG
    Int J Stroke; 2011 Jun; 6(3):207-8. PubMed ID: 21557805
    [No Abstract]   [Full Text] [Related]  

  • 25. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score.
    Smith JG; Wieloch M; Koul S; Braun OÖ; Lumsden J; Rydell E; Ohman J; Scherstén F; Svensson PJ; van der Pals J
    EuroIntervention; 2012 Oct; 8(6):672-8. PubMed ID: 23086784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators.
    JAMA; 1998 Apr 22-29; 279(16):1273-7. PubMed ID: 9565007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of emerging antithrombotic therapy in the prevention of cardioembolic complications in patients with atrial fibrillation.
    Deedwania PC; Huang GW
    Am J Cardiovasc Drugs; 2011 Aug; 11(4):265-75. PubMed ID: 21740079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antithrombotic treatment in atrial fibrillation.
    Lip GY; Boos CJ
    Postgrad Med J; 2008 May; 84(991):252-8. PubMed ID: 18508982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clopidogrel plus aspirin in atrial fibrillation.
    Pisters R; Dinh T; Crijns HJ
    N Engl J Med; 2009 Sep; 361(13):1312; author reply 1314-5. PubMed ID: 19776416
    [No Abstract]   [Full Text] [Related]  

  • 31. Preventing stroke in patients with atrial fibrillation: current treatments and new concepts.
    Connolly SJ
    Am Heart J; 2003 Mar; 145(3):418-23. PubMed ID: 12660663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clopidogrel as antithrombotic therapy in atrial fibrillation.
    Veloso HH; de Paola AA
    Chest; 2005 Jul; 128(1):475; author reply 475. PubMed ID: 16002984
    [No Abstract]   [Full Text] [Related]  

  • 33. Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial.
    Diener HC; Eikelboom J; Connolly SJ; Joyner CD; Hart RG; Lip GY; O'Donnell M; Hohnloser SH; Hankey GJ; Shestakovska O; Yusuf S;
    Lancet Neurol; 2012 Mar; 11(3):225-31. PubMed ID: 22305462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial.
    Alexander JH; Lopes RD; Thomas L; Alings M; Atar D; Aylward P; Goto S; Hanna M; Huber K; Husted S; Lewis BS; McMurray JJ; Pais P; Pouleur H; Steg PG; Verheugt FW; Wojdyla DM; Granger CB; Wallentin L
    Eur Heart J; 2014 Jan; 35(4):224-32. PubMed ID: 24144788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clopidogrel hydrogen sulphate for atrial fibrillation.
    Garg N; Rajpurohit N; Flaker G
    Expert Opin Pharmacother; 2011 Aug; 12(11):1781-7. PubMed ID: 21663525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1.
    Gorin L; Fauchier L; Nonin E; de Labriolle A; Haguenoer K; Cosnay P; Babuty D; Charbonnier B
    Thromb Haemost; 2010 Apr; 103(4):833-40. PubMed ID: 20135077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimizing antiplatelet therapy in high-risk patients with atrial fibrillation: insights from Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events (ACTIVE A).
    Seet RC; Chen CP
    Stroke; 2009 Dec; 40(12):3883-5. PubMed ID: 19875732
    [No Abstract]   [Full Text] [Related]  

  • 38. Triple antithrombotic therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation.
    Kang DO; Yu CW; Kim HD; Cho JY; Joo HJ; Choi RK; Park JS; Lee HJ; Kim JS; Park JH; Hong SJ; Lim DS
    Coron Artery Dis; 2015 Aug; 26(5):372-80. PubMed ID: 25768244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic considerations for antithrombotic therapies in stroke.
    Apostolakis S; Lip GY; Shantsila E
    Expert Opin Drug Metab Toxicol; 2013 Oct; 9(10):1335-47. PubMed ID: 23750513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study.
    O'Donnell M; Oczkowski W; Fang J; Kearon C; Silva J; Bradley C; Guyatt G; Gould L; D'Uva C; Kapral M; Silver F;
    Lancet Neurol; 2006 Sep; 5(9):749-54. PubMed ID: 16914403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.